ZYBT
Zhengye Biotechnology Holding Limited
1.30$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
Zhengye Biotechnology Holding Limited (ZYBT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 116 million CNY. Tick rows to compare them in a chart.
All figures in millions of CNY.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 214 | 260 | 212 | 186 | 116 | |
| 89 | 107 | 82 | 95 | 92 | |
| 125 | 154 | 130 | 91 | 24 | |
| 11 | 13 | 12 | 13 | 18 | |
| 22 | 29 | 26 | 64 | 31 | |
| 73 | 88 | 85 | 169 | 92 | |
| 52 | 66 | 45 | 17 | -68 | |
| 1.0 | 2.8 | 4.4 | 4.0 | 3.4 | |
| 53 | 64 | 44 | 14 | -72 | |
| 6.6 | 8.2 | 6.3 | – | 11 | |
| 39 | 47 | 31 | 11 | -70 | |
| 70 | 86 | 72 | – | -43 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.